Page last updated: 2024-09-03

gefitinib and sesquiterpenes

gefitinib has been researched along with sesquiterpenes in 4 studies

Compound Research Comparison

Studies (gefitinib)	Trials (gefitinib)	Recent Studies (post-2010) (gefitinib)	Studies (sesquiterpenes)	Trials (sesquiterpenes)	Recent Studies (post-2010) (sesquiterpenes)
5,231	566	2,919	17,489	536	7,668

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	1 (25.00)	2.80

Authors

Authors	Studies
Sánchez De Cos Escuín, J	1
Filov, VA; Gershanovich, ML; Imianitov, EN; Stukov, AN	1
Chen, Y; Mu, L; Tang, X; Wang, T; Yuan, Y; Zhao, Y	1
Chen, X; Han, X; Jin, T; Li, G; Li, Q; Liu, S; Lv, Q; Pan, T; Sui, X; Wang, J; Xie, T; Yan, L; Zhang, M; Zhang, Q; Zhuo, L	1

Reviews

2 review(s) available for gefitinib and sesquiterpenes

Article	Year
[New therapeutic targets and strategies in lung cancer]. Archivos de bronconeumologia, 2002, Volume: 38, Issue:8 Topics: Alkyl and Aryl Transferases; Angiogenesis Inhibitors; Antineoplastic Agents; Benzamides; Benzodiazepines; Clinical Trials as Topic; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Endothelial Growth Factors; Enzyme Inhibitors; Epidermal Growth Factor; ErbB Receptors; Erlotinib Hydrochloride; Farnesyltranstransferase; Gefitinib; Humans; Imatinib Mesylate; Imidazoles; Intercellular Signaling Peptides and Proteins; Lung Neoplasms; Lymphokines; Metalloendopeptidases; Multicenter Studies as Topic; Piperazines; Polyisoprenyl Phosphates; Protein-Tyrosine Kinases; Pyrimidines; Quinazolines; Quinolones; Randomized Controlled Trials as Topic; Receptor Protein-Tyrosine Kinases; Sesquiterpenes; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	2002
[Problems in the current target therapy of malignancies]. Voprosy onkologii, 2005, Volume: 51, Issue:5 Topics: Alemtuzumab; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antibodies, Neoplasm; Antineoplastic Agents; Azathioprine; Benzamides; Bevacizumab; Cetuximab; Erlotinib Hydrochloride; Gefitinib; Humans; Imatinib Mesylate; Neoplasms; Phthalazines; Piperazines; Pyridines; Pyrimidines; Quinazolines; Quinolones; Rituximab; Sesquiterpenes; Sesquiterpenes, Guaiane; Trastuzumab	2005

Article

Year

[New therapeutic targets and strategies in lung cancer].

Archivos de bronconeumologia, 2002, Volume: 38, Issue:8

Topics: Alkyl and Aryl Transferases; Angiogenesis Inhibitors; Antineoplastic Agents; Benzamides; Benzodiazepines; Clinical Trials as Topic; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Endothelial Growth Factors; Enzyme Inhibitors; Epidermal Growth Factor; ErbB Receptors; Erlotinib Hydrochloride; Farnesyltranstransferase; Gefitinib; Humans; Imatinib Mesylate; Imidazoles; Intercellular Signaling Peptides and Proteins; Lung Neoplasms; Lymphokines; Metalloendopeptidases; Multicenter Studies as Topic; Piperazines; Polyisoprenyl Phosphates; Protein-Tyrosine Kinases; Pyrimidines; Quinazolines; Quinolones; Randomized Controlled Trials as Topic; Receptor Protein-Tyrosine Kinases; Sesquiterpenes; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

2002

[Problems in the current target therapy of malignancies].

Voprosy onkologii, 2005, Volume: 51, Issue:5

Topics: Alemtuzumab; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antibodies, Neoplasm; Antineoplastic Agents; Azathioprine; Benzamides; Bevacizumab; Cetuximab; Erlotinib Hydrochloride; Gefitinib; Humans; Imatinib Mesylate; Neoplasms; Phthalazines; Piperazines; Pyridines; Pyrimidines; Quinazolines; Quinolones; Rituximab; Sesquiterpenes; Sesquiterpenes, Guaiane; Trastuzumab

2005

Other Studies

2 other study(ies) available for gefitinib and sesquiterpenes

Article	Year
β-Elemene enhances the efficacy of gefitinib on glioblastoma multiforme cells through the inhibition of the EGFR signaling pathway. International journal of oncology, 2016, Volume: 49, Issue:4 Topics: Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Synergism; ErbB Receptors; Gefitinib; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Quinazolines; Sesquiterpenes; Signal Transduction	2016
The mechanism of m Cell death & disease, 2020, 11-11, Volume: 11, Issue:11 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Autophagy; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Drug Synergism; Female; Gefitinib; Humans; Lung Neoplasms; Methyltransferases; Mice; Mice, Inbred BALB C; Mice, Nude; Models, Molecular; Random Allocation; Sesquiterpenes; Xenograft Model Antitumor Assays	2020

Article

Year

β-Elemene enhances the efficacy of gefitinib on glioblastoma multiforme cells through the inhibition of the EGFR signaling pathway.

International journal of oncology, 2016, Volume: 49, Issue:4

Topics: Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Synergism; ErbB Receptors; Gefitinib; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Quinazolines; Sesquiterpenes; Signal Transduction

2016

The mechanism of m

Cell death & disease, 2020, 11-11, Volume: 11, Issue:11

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Autophagy; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Drug Synergism; Female; Gefitinib; Humans; Lung Neoplasms; Methyltransferases; Mice; Mice, Inbred BALB C; Mice, Nude; Models, Molecular; Random Allocation; Sesquiterpenes; Xenograft Model Antitumor Assays

2020